Proton pump inhibitors are widely prescribed for unlicensed non-specific abdominal symptoms

There has been much speculation about the reasons behind the substantial rise in prescribing of proton pump inhibitors; in particular, their use for minor symptoms. Bashford et al (p 452) used the General Practitioner Research Database for the former West Midlands region to show that, between 1991 and 1995, overall prescribing of these drugs rose 10-fold, but unlicensed use remained high, at 46% in 1995. These changes in prescribing resulted in increases in the proportion of new prescriptions for non-specific abdominal symptoms and ulcer disease and a decrease for gastro-oesophageal reflux disease. The authors also analysed prescribing analyses and cost (PACT) data and found similar prescribing trends to those recorded with the General Practitioner Research Database.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database
James N R Bashford, Jeff Norwood, and Stephen R Chapman
BMJ 1998 317: 452-456. [Abstract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ